30.08.2011 • News

Richard DeLuca Named President, Merck Animal Health

Merck & Co. said it appointed Richard DeLuca Jr. as executive vice president and president, Merck Animal Health, effective Sept. 15. DeLuca will report to Kenneth Frazier, Merck's president and chief executive, and would serve on the company's executive committee.

DeLuca is succeeding Raul Kohan, who has decided to retire from the company. Kohan will remain with the company until the end of the year. Merck noted that DeLuca would leverage the division's strong product portfolio and customer focus to capitalize on new growth opportunities, including expanding the business in emerging markets.

DeLuca has served as chief financial officer of BD Biosciences since 2010.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read